Bloomberg Stock Movers
2026-08-11 · Hosted by — · Bloomberg / iHeartMedia
Executive Summary
This Stock Movers segment covered a busy pre-market earnings morning. Cardinal Health rose 3% on a strong fiscal 2027 earnings outlook, while On Holding fell 16% after missing sales estimates and softening full-year growth guidance. Intel's stock offering was upsized to $20 billion from $15 billion after drawing roughly $100 billion in demand, with shares priced at a relatively tight 6.5% discount, though the stock still slipped about 1% on the news.
Key Stories & Changes
1. Cardinal Health Beats on Strong Outlook
Shares rose 3% pre-market as the company guided fiscal 2027 adjusted earnings to $12.40-$12.60, above the $12.06 estimate
Fiscal Q4 adjusted earnings came in at $2.91, roughly 50 cents above Wall Street expectations
Revenue was a slight miss at $63.7 billion
Guided pharma revenue growth of 3-5% and global medical products growth of 2-4%
2. On Holding Drops on Guidance Cut
Shares fell 16% pre-market after the Swiss sneaker maker posted net sales of 850 million Swiss francs (just over $1 billion), missing estimates
Full-year sales guidance softened to low 20% growth, down from prior guidance of 23% or higher
Company is holding more inventory of older models while launching new versions; management said strong direct-to-consumer channels are why it has resisted discounting, aiming to be the "most premium global sports brand"
3. Intel Upsizes Share Offering to $20 Billion
Intel raised its offering size to $20 billion from the previously announced $15 billion after seeing roughly $100 billion in investor demand
Offering priced at $95 per share, just a 6.5% discount to Friday's close — a tight discount for a volatile stock, signaling strong demand
Shares still fell about 1%
Comes alongside Alphabet raising $85 billion via equity sale and Oracle planning to raise $20 billion
4. Riot Platforms Surges on $9 Billion Anthropic Deal
Shares jumped 18% pre-market after Riot — a former biotech-turned-Bitcoin-miner-turned-data-center-provider — signed a 20-year deal identified by sources as being with Anthropic
Deal covers 191 megawatts of capacity, enough to power roughly 143,000 homes, with an extension option that could bring total sales to $16 billion
Company also posted a revenue beat, further lifting shares
5. Rocket Lab Falls on Neutron Delay Concerns
Shares fell 6% on concerns its Neutron rocket — designed to compete with SpaceX's Falcon 9 — may not launch this year as previously targeted
Company said the rocket will be delivered to the launch pad in Q4 but stopped short of confirming a 2026 flight
Adjusted loss per share of $0.08, a penny wider than estimates
Trends Identified
1. Equity Markets Absorbing a Wave of Large Tech Capital Raises
Intel's upsized $20 billion offering, alongside Alphabet's $85 billion raise and Oracle's planned $20 billion raise, shows major tech companies increasingly turning to public equity markets to fund AI infrastructure buildout, with strong investor demand evidenced by tight pricing discounts.
2. AI Compute Demand Is Reshaping Non-Tech Business Models
Riot Platforms' pivot from biotech to Bitcoin mining to AI data center provider — culminating in a $9 billion Anthropic deal — illustrates how surging AI compute demand is pulling companies from unrelated industries into the data center infrastructure business. ---
Sentiment Analysis
Overall Market Sentiment: Mixed, Earnings-Driven
Reactions were sharply differentiated by company-specific results, with strong AI infrastructure demand and earnings beats rewarded, while guidance cuts and delays punished.
Risk Factors Highlighted
On Holding inventory overhang: Elevated older-model inventory amid new launches signals potential margin or pricing pressure ahead.
Intel dilution from upsized offering: A larger-than-announced raise increases shareholder dilution even as demand remains strong.
Rocket Lab launch timeline risk: Neutron's delivery-to-pad timing leaves open the possibility of a 2027 launch slip, dependent on booster testing outcomes.
Revenue softness at Cardinal Health: A slight revenue miss alongside the earnings beat suggests some underlying demand softness.
This episode was covered in today's [The Market Signal — 2026-08-11](https://marketsignal.beehiiv.com/p/the-market-signal-2026-08-11), a cross-source synthesis of multiple podcast reports.